載入...
Reduced intensity allogeneic hematopoietic stem cell transplantion for MDS using tacrolimus/sirolimus-based GVHD prophylaxis
We report a consecutive series of 59 patients with MDS who underwent reduced-intensity hematopoietic stem cell transplantation (RI-HSCT) with fludarabine/melphalan conditioning and tacrolimus/sirolimus-based GVHD prophylaxis. Two-year OS, EFS, and relapse incidences were 75.1%, 65.2%, and 20.9%, res...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3433241/ https://ncbi.nlm.nih.gov/pubmed/22677229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.04.022 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|